Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Amgen grants MedImmune rights to develop AMG-108 worldwide outside Japan

Jan. 11, 2011

Ziopharm Oncology and Intrexon partner to develop DNA-based oncology therapeutics

Jan. 10, 2011

Spectrum Pharma and Viropro sign agreement for development of rituximab biosimilar

Jan. 10, 2011

Amgen and Xencor to jointly develop XmAb-5871

Jan. 10, 2011

Cynapsus and IntelGenx sign definitive license agreement for INT-0010

Jan. 7, 2011

Omeros licenses new antifibrinolytic agents from University of California

Jan. 7, 2011

Mercator Therapeutics and Pepscan Therapeutics join to optimize anticancer homing peptides

Jan. 7, 2011

Xoma and Servier sign agreement for anti-inflammatory candidate XOMA-052

Jan. 5, 2011

Santaris expands alliance with Pfizer for RNA-targeted medicines

Jan. 5, 2011

Kiadis Pharma and Hospira collaborate to develop ATIR

Jan. 5, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Will Ovid’s golden age of KCC2 metamorph CNS?
BioWorld
The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...
BMS-Hengrui deal strikes panic in Washington
BioWorld
On the heels of the multibillion-dollar licensing deal between Bristol Myers Squibb Co. and Jiangsu Hengrui Pharmaceuticals Co. Ltd., Chairman John Moolenaar...